No greater CV benefit with fenofibrate plus statin vs. statin alone in diabetes
Links shared publicly online about this topic.
- 1,314total visits
No greater CV benefit with fenofibrate plus statin vs. statin alone in diabetes
American College of Cardiology 59th Annual Scientific Sessions ATLANTA " The addition of fenofibrate to simvastatin therapy failed to reduce
View full resource at endocrinetoday.com
Tags: Heart, Cholesterol Medication, Diabetes, Zocor, TriCor, Lipanthyl, Cardiology
Most Recently Shared on March 14, 2010 at 11:05 pm By:
More from the ACCORD trial at #ACC10: No greater CV benefit with fenofibrate plus statin vs. statin alone in #diabetes http://ow.ly/1ktx0
Advertisement
